Predictors and outcomes of antibiotic adequacy for bloodstream infections in veterans with spinal cord injury

Arch Phys Med Rehabil. 2009 Aug;90(8):1364-70. doi: 10.1016/j.apmr.2009.02.012.

Abstract

Objective: To identify predictors and outcomes associated with receiving inadequate empirical antimicrobial treatment for bloodstream infections (BSIs) in persons with spinal cord injury (SCI).

Design: Retrospective cohort study from October 1, 1997, through September 30, 2004.

Setting: A Department of Veterans Affairs SCI center that serves approximately 700 patients a year.

Participants: Hospitalized patients with SCI (N=123) who had 1 or more BSIs during the study period.

Interventions: Not applicable.

Main outcome measures: Adequacy of antimicrobial treatment (inadequate treatment was defined as the absence of antimicrobial agents for a particular organism within 2 days after the collection of blood cultures and/or the microorganism's resistance to the antimicrobial administered), hospital length of stay (LOS) post-BSI infection, and in-hospital and 30-day mortality. Cluster-adjusted multivariable models were assessed.

Results: Over one third (88; 37.4%) of the 235 episodes of BSI identified received inadequate empirical antibiotic treatment. Having a polymicrobial BSI was associated with inadequate treatment (odds ratio [OR]=3.28; 95% confidence interval [CI]=1.62-6.65; P=.001). Factors protective against inadequate therapy included having a comorbid pressure ulcer (OR=0.37; 95% CI=0.21-0.68; P=.001) or a BSI that was not primary (OR=0.30; 95% CI=0.15-0.58; P<.0001). Mortality did not differ between the inadequate and adequate treatment groups (11.4% vs 10.9%; P=.92). Similarly LOS postinfection was not affected by treatment status (inadequate treatment median=22d vs adequate treatment median=27d; P=.98).

Conclusions: Over one third of patients received inadequate empirical treatment, which was associated with having a polymicrobial BSI. However, inadequate treatment was not associated with increased mortality or LOS postinfection.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / administration & dosage*
  • Bacteremia / drug therapy*
  • Bacteremia / etiology
  • Bacteremia / mortality
  • Comorbidity
  • Cross Infection / drug therapy*
  • Cross Infection / etiology
  • Cross Infection / mortality
  • Drug Resistance, Microbial
  • Female
  • Hospital Mortality
  • Hospitals, Veterans
  • Humans
  • Inpatients
  • Length of Stay / statistics & numerical data
  • Logistic Models
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Spinal Cord Injuries / complications*
  • United States
  • Veterans*

Substances

  • Anti-Bacterial Agents